IFNG and cancer: The concordances between the IFN-γ responses of QFT-Plus TB1 or TB2 and QFT-GIT TB were relatively poorer in the long-term immunosuppressant therapy group than in the liver/kidney failure, malignant tumors, and invasive fungal infection groups (Table 3).